SP

Sonia Prashant Thakur

Active Director Director DIN 10800583
DIN 10800583 First appointment Oct 2024 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Oct 2024
Shareholding value •••• Premium profile

About Sonia Prashant Thakur

Data last updated:

Sonia Prashant Thakur is a Director at Maxxsun Pharmaceuticals Private Limited (since 2024). The company operates in Pharma. Maxxsun Pharmaceuticals Private Limited reported revenue of ₹5.07 Cr (FY 2025).

DIN 10800583
Primary Designation Director
Industry Pharma
First Appointment 07 Oct 2024
Oldest Company Age 2 yrs
Largest company Maxxsun Pharmaceuticals Private Limited · ₹5.07 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director07 Oct 20242024₹5.07 Cr (FY 2025)Active

Board colleagues of Sonia Prashant Thakur

Directorship timeline

Open interactive timeline →
Maxxsun Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Sonia Prashant Thakur

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Sonia Prashant Thakur

Sonia Prashant Thakur currently holds 1 directorship: Maxxsun Pharmaceuticals Private Limited (Director, since 07 Oct 2024, revenue ₹5.07 Cr (FY 2025)).

Sonia Prashant Thakur was first appointed on 07 Oct 2024 as Director at Maxxsun Pharmaceuticals Private Limited.

The current boards of Sonia Prashant Thakur's companies include Anish Pundlik Sadadekar (Maxxsun Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available